Segall Bryant & Hamill’s Diebold Nixdorf Incorporated DBD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-49,850
Closed -$526K 854
2019
Q4
$526K Sell
49,850
-301
-0.6% -$2.67K 0.01% 651
2019
Q3
$561K Sell
50,151
-21,141
-30% -$250K 0.01% 632
2019
Q2
$653K Buy
71,292
+9,726
+16% +$101K 0.01% 620
2019
Q1
$681K Buy
+61,566
New +$430K 0.01% 610

Other funds holding DBD

Segall Bryant & Hamill's DBD Position: Q1 2020 in Review

Segall Bryant & Hamill sold out of Diebold Nixdorf Incorporated (DBD) in Q1 2020, closing a stake of 49,850 shares — an estimated $526K sold.

Segall Bryant & Hamill first reported a position in DBD in Q1 2019 and held it in 4 quarters. The position peaked at $681K in Q1 2019. 170 funds tracked by Wall St. Rank hold DBD as of Q1 2020.

  • Segall Bryant & Hamill reported no remaining Diebold Nixdorf Incorporated position as of Q1 2020 after selling out during the quarter.
  • Segall Bryant & Hamill sold 49,850 Diebold Nixdorf Incorporated shares in Q1 2020, an estimated $526K.
  • Segall Bryant & Hamill first reported a position in Diebold Nixdorf Incorporated in Q1 2019 and held it in 4 quarters.
  • Segall Bryant & Hamill's Diebold Nixdorf Incorporated position peaked at $681K in Q1 2019.
  • 170 funds tracked by Wall St. Rank held Diebold Nixdorf Incorporated as of Q1 2020.

Based on Segall Bryant & Hamill's 13F filing for Q1 2020, filed 14 May 2020.